Studies | Outcomes which were reported after PCI in the original studies respectively | Follow-up time period after PCI | Types of CAD |
---|---|---|---|
Ayoub 2018 [8] | Post-procedural hemorrhage, RBC transfusion, platelet transfusion, vascular complications, acute ischemic CVA, acute hemorrhagic CVA, cardiac tamponade, mortality | In-hospital | General population with CAD + chronic thrombocytopenia undergoing PCI |
Ito 2018 [9] | Myocardial infarction, GUSTO moderate bleeding, GUSTO severe bleeding, all-cause death, cardiac death, ischemic stroke, all stroke, hemorrhagic stroke, definite stent thrombosis, definite/probable stent thrombosis, any coronary revascularization, intracranial bleeding, gastrointestinal bleeding, bleeding related to surgery, bleeding related to catheterization procedure | 3 years | General population with CAD + thrombocytopenia undergoing PCI |
Kiviniemi 2013 [10] | All-cause mortality, MACCE, stroke, peripheral arterial embolism, myocardial infarction, revascularization, stent thrombosis, venous thromboembolism, total bleeding events, minor BARC 2 bleeding, major BARC bleeding (3a, 3b, 3c, 5) | 1 year | CAD and atrial fibrillation + thrombocytopenia undergoing PCI |
Liu 2018 [11] | All-cause mortality, cardiac death, myocardial infarction, revascularization, bleeding, major bleeding, ischemic stroke, MACE, definite stent thrombosis, definite and probable stent thrombosis, early, late and very late stent thrombosis | 30 months | General population with CAD + thrombocytopenia undergoing elective PCI |
Overgaard 2008 [12] | Mortality, MACE, myocardial infarction, major bleeding, gastro-intestinal bleed, intracranial hemorrhage, other bleedings, access site complications, transfusion | In-hospital | General population with CAD + thrombocytopenia undergoing PCI |
Raphael 2016 [13] | Femoral bleeding, intra-cerebral bleeding, hematoma, gastro-intestinal bleeding, retroperitoneal bleeding, any bleeding, death, myocardial infarction, access site bleeding, BARC 2 minor bleeding, BARC (3a, 3b, 4) major bleeding | In-hospital | General population with CAD + thrombocytopenia undergoing PCI |
Shiraishi 2019 [14] | Mortality, transfusion, access site bleeding | In-hospital | General population with CAD + thrombocytopenia undergoing elective PCI |
Yadav 2016 [15] | Death, cardiac death, myocardial infarction, revascularization, definite/probable stent thrombosis, MACE | 1 year | ACS (STEMI and NSTEMI) + thrombocytopenia undergoing PCI |